Reuters / Thursday, September 23, 2021
A registered nurse attempts to find a vein to administer the Regeneron
monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing
positive for the coronavirus, at the Sarasota Memorial Urgent Care Center in
Sarasota, Florida. REUTERS/Shannon Stapleto
Yesterday, the World Health
Organization recommended Regeneron’s monoclonal antibody treatment for Covid-19. The
global body says the combination treatment can be used in COVID-19 patients who
are at high risk of severe disease as well as in severe and critically ill
COVID-19 patients who have not yet developed antibodies.
No comments:
Post a Comment